Publication Details

Pubmed17333335
Title: Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.
Year: 2007
DOI: https://doi.org/10.1007/s10549-007-9535-6
First Author: Journe
Experimental setup: affinity chromatography technology (Biogrid)
in vivo (Hprd)
anti bait coimmunoprecipitation (IntAct)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
ESR1_HUMANNR1H4_HUMANBioGRID, HPRD, IntActdetails